Moreover, MHC II, a protein linked to the genetic risk for PD, mediates the recognition of antigens presented on the microglial surface by T cells and is critical for the activation of both innate and adaptive immune responses to α-synuclein in PD [209]. The gene discussed is SNCA; the disease is Parkinson disease.